<DOC>
	<DOCNO>NCT00480961</DOCNO>
	<brief_summary>This research study design test safety effectiveness autologous stem cell graft myocardium patient refractory Congestive Heart Failure ( CHF ) ischemic etiology . Cellular implantation take place off-pump revascularization surgery ad hoc procedure use mini-thoracotomy access .</brief_summary>
	<brief_title>Congestive Heart Failure Surgical Treatmment With Autologous Stem Cell Therapy</brief_title>
	<detailed_description>Primary target : determine safety introduce CD 34+ autologous progenitor cell ( centrally graft mobilized peripheral blood ) myocardium ischemic cardiac disease patient . Secondary target : determine clinical effect graft cell remodel pathology .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Inclusion criterion Age &gt; 18 y/o CHF EF &gt; 35 % Bilirubinemia , serum transaminase &gt; 2.5 time normal max level Creatininemia &gt; 2.5 time max level NYHA Class &gt; 3 Negative pregnancy test ( woman fertile age ) Exclusion criterion Impossibility harvest bone marrow Pregnancy breastfeed History malignant neoplasia 5year period study ( save insitu carcinoma cervix treat successfully skin tumor â€“ melanoma ) Incapability unwillingness comply envisage treatment protocol , followup , test .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2007</verification_date>
</DOC>